Related references
Note: Only part of the references are listed.Monkeypox: A potential global threat?
Zhilong Yang
JOURNAL OF MEDICAL VIROLOGY (2022)
Clinical features and management of human monkeypox: a retrospective observational study in the UK
Hugh Adler et al.
LANCET INFECTIOUS DISEASES (2022)
Monkeypox in 2022-What Clinicians Need to Know
Jeannette Guarner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications
Andrew T. Russo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research
Mary G. Reynolds et al.
VIRUSES-BASEL (2017)
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II
Nancy F. Crum-Cianflone et al.
INFECTIOUS DISEASES AND THERAPY (2017)
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox
Greg Chittick et al.
ANTIVIRAL RESEARCH (2017)
Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
Brett W. Petersen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - An animal model of smallpox
Scott Parker et al.
ANTIVIRAL RESEARCH (2012)
Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
Amanda D. Rice et al.
VIRUSES-BASEL (2011)
Development of CMX001 for the Treatment of Poxvirus Infections
Randall Lanier et al.
VIRUSES-BASEL (2010)
Severe eczema vaccinatum in a household contact of a smallpox vaccinee
Surabhi Vora et al.
CLINICAL INFECTIOUS DISEASES (2008)
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice
Debra C. Quenelle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy
R Wittek
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2006)
Reemergence of monkeypox: Prevalence, diagnostics, and countermeasures
A Nalca et al.
CLINICAL INFECTIOUS DISEASES (2005)
Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox
E Hammarlund et al.
NATURE MEDICINE (2005)
Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections
R Baker et al.
ANTIVIRAL RESEARCH (2003)
Share Paper
